STOCK TITAN

Core Laboratories (CLB) Stock News, Jun-Sep 2020

CLB NYSE

Core Laboratories Inc. reports news on reservoir description and production enhancement services and products for the oil and gas industry. Company updates commonly cover quarterly results, operating income, margins, free cash flow, net debt, leverage, dividends and common-stock repurchases, along with demand trends across conventional, unconventional, onshore and offshore projects.

Core Lab news also includes project and technology developments tied to petroleum reservoir performance, including laboratory analysis, formation evaluation, proprietary tracers such as SpectraStim, and services used by operators in major producing regions. Updates may address acquisitions that expand geological-service capabilities, regional operating disruptions, client project timing and supply-chain conditions that affect energy-service activity.

Rhea-AI Summary

Core Laboratories (NYSE: CLB) will host its third quarter 2020 conference call on October 22, 2020, at 7:30 a.m. CDT / 2:30 p.m. CEST. Key executives including CEO Larry Bruno and CFO Chris Hill will discuss financial and operational results. An earnings press release will be available after market close on October 21. Interested participants can join the live webcast on the company's website, with a replay available for ten days. Core Laboratories operates over 70 offices globally, providing services to optimize petroleum reservoir performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.23%
Tags
-
Rhea-AI Summary

Core Laboratories N.V. (CLB) reported second-quarter 2020 revenue of $115.7 million, which includes a $13.3 million charge related to severance and inventory write-downs. The company recorded an operating loss of $2.6 million and a diluted loss per share of $0.13, while operating income, excluding items, was $10.7 million with margins of 9.2%. Core generated free cash flow of $23.9 million, marking its 75th consecutive quarter of positive cash flow. Cost reductions of approximately $61 million annually were initiated in response to COVID-19 disruptions, with expectations for further alignment with client activities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.06%
Tags
-
Rhea-AI Summary

Core Laboratories N.V. (NYSE: CLB) announced a cash dividend of $0.01 per share for Q3 2020, payable on August 10, 2020, to shareholders of record as of July 27, 2020. This follows a $0.25 dividend in Q1 2020 and another $0.01 in Q2, bringing the total dividend payout for 2020 to $0.28 per share if maintained. Future dividends will depend on the Company’s financial standing, earnings outlook, capital plans, and other relevant factors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.39%
Tags
dividends earnings
News
Rhea-AI Summary

Core Laboratories N.V. (CLB) announced an amendment to its revolving credit facility on June 22, 2020, increasing the maximum leverage ratio from 2.50:1.00 to 3.00:1.00 amid COVID-19 impacts on the oil and gas sector. The credit facility's size was reduced from $300 million to $225 million, allowing more flexibility under current market conditions. Cost-cutting initiatives are projected to yield $61 million in annual savings. Despite challenges, Core Lab aims to maintain liquidity and navigate ongoing disruptions efficiently.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.89%
Tags
none

FAQ

What is the current stock price of Core Laboratories (CLB)?

Core Laboratories (CLB) last closed at $9.11.

What is the market cap of Core Laboratories (CLB)?

The market cap of Core Laboratories (CLB) is approximately $417.4M.